ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

KRMD KORU Medical Systems Inc

4.63
0.23 (5.23%)
14 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
KORU Medical Systems Inc NASDAQ:KRMD NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.23 5.23% 4.63 3.45 4.75 4.60 4.2367 4.40 206,263 01:00:00

KORU Medical Systems to Participate in Upcoming Investor Conferences

06/11/2024 9:05pm

Business Wire


KORU Medical Systems (NASDAQ:KRMD)
Historical Stock Chart


From Oct 2024 to Dec 2024

Click Here for more KORU Medical Systems Charts.

 

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will be participating in two upcoming Investor Conferences.

KORU Medical’s management team is participating at the 15th Annual Craig-Hallum Alpha Select Conference on Tuesday, November 19th, 2024.

KORU Medical’s management team will also be participating at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 21st, 2024.

About KORU Medical Systems

KORU Medical develops, manufactures, and commercializes innovative and patient-centric large volume subcutaneous infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System (the “Freedom System”) currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. The Freedom System, which received its first FDA clearance in 1994, is used for self-administration in the home by the patient and/or delivery in an ambulatory infusion center by a healthcare professional. Through its Novel Therapies business, KORU Medical provides products for use by biopharmaceutical companies in feasibility/clinical trials during the drug development process and, as needed, is capable of customizing the Freedom System for clinical and commercial use across multiple drug categories. For more information, please visit www.korumedical.com.

Investor Contact: Louisa Smith investor@korumedical.com

1 Year KORU Medical Systems Chart

1 Year KORU Medical Systems Chart

1 Month KORU Medical Systems Chart

1 Month KORU Medical Systems Chart

Your Recent History

Delayed Upgrade Clock